Arlene A. Forastiere

Phase II trial of taxol in salivary gland malignancies (E1394): A trial of the Eastern Cooperative Oncology Group

J. Gilbert, M. Kies, Yi Li, 2006, Head & neck.

A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck

A. Argiris, B. Burtness, R. Axelrod, 2011, Cancer.

Is open surgery for head and neck cancers truly declining?

J. Shah, J. Werner, D. Brasnu, 2013, European Archives of Oto-Rhino-Laryngology.

Cisplatin and mitoguazone: An induction chemotherapy regimen in advanced head and neck cancer

G. Wolf, R. Wheeler, R. Natale, 1988, Cancer.

Phase II trial of methylglyoxal bis (guanylhydrazone) (MGBG) in advanced head and neck cancer

R. R. Wheeler, R. Natale, Arlene A. Forastiere, 1986, Cancer.

Quality of care and short‐ and long‐term outcomes of laryngeal cancer care in the elderly

H. Quon, S. Dy, K. Frick, 2015, The Laryngoscope.

Short‐ and long‐term outcomes of laryngeal cancer care in the elderly

H. Quon, K. Frick, Heather M. Starmer, 2015, The Laryngoscope.

Treatment, survival, and costs of laryngeal cancer care in the elderly

H. Quon, S. Dy, A. Blackford, 2014, The Laryngoscope.